112 related articles for article (PubMed ID: 38212846)
21. Role of caspase-3 in tau truncation at D421 is restricted in transgenic mouse models for tauopathies.
Zhang Q; Zhang X; Chen J; Miao Y; Sun A
J Neurochem; 2009 Apr; 109(2):476-84. PubMed ID: 19200347
[TBL] [Abstract][Full Text] [Related]
22. Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies.
Comerota MM; Tumurbaatar B; Krishnan B; Kayed R; Taglialatela G
Mol Neurobiol; 2019 May; 56(5):3341-3355. PubMed ID: 30120733
[TBL] [Abstract][Full Text] [Related]
23. Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.
Arner A; Rockenstein E; Mante M; Florio J; Masliah D; Salehi B; Adame A; Overk C; Masliah E; Rissman RA
J Alzheimers Dis; 2018; 61(3):1201-1219. PubMed ID: 29332037
[TBL] [Abstract][Full Text] [Related]
24. Expression of a truncated human tau protein induces aqueous-phase free radicals in a rat model of tauopathy: implications for targeted antioxidative therapy.
Cente M; Filipcik P; Mandakova S; Zilka N; Krajciova G; Novak M
J Alzheimers Dis; 2009; 17(4):913-20. PubMed ID: 19542619
[TBL] [Abstract][Full Text] [Related]
25. Peripheral nervous system effects in the PS19 tau transgenic mouse model of tauopathy.
Merchán-Rubira J; Sebastián-Serrano Á; Díaz-Hernández M; Avila J; Hernández F
Neurosci Lett; 2019 Apr; 698():204-208. PubMed ID: 30677432
[TBL] [Abstract][Full Text] [Related]
26. Tau isoform regulation is region- and cell-specific in mouse brain.
McMillan P; Korvatska E; Poorkaj P; Evstafjeva Z; Robinson L; Greenup L; Leverenz J; Schellenberg GD; D'Souza I
J Comp Neurol; 2008 Dec; 511(6):788-803. PubMed ID: 18925637
[TBL] [Abstract][Full Text] [Related]
27. Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice.
Ikeda M; Shoji M; Kawarai T; Kawarabayashi T; Matsubara E; Murakami T; Sasaki A; Tomidokoro Y; Ikarashi Y; Kuribara H; Ishiguro K; Hasegawa M; Yen SH; Chishti MA; Harigaya Y; Abe K; Okamoto K; St George-Hyslop P; Westaway D
Am J Pathol; 2005 Feb; 166(2):521-31. PubMed ID: 15681835
[TBL] [Abstract][Full Text] [Related]
28. Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model.
Green C; Sydow A; Vogel S; Anglada-Huguet M; Wiedermann D; Mandelkow E; Mandelkow EM; Hoehn M
Mol Neurodegener; 2019 Mar; 14(1):13. PubMed ID: 30917861
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and Assessment of Novel Probes for Imaging Tau Pathology in Transgenic Mouse and Rat Models.
McMurray L; Macdonald JA; Ramakrishnan NK; Zhao Y; Williamson DW; Tietz O; Zhou X; Kealey S; Fagan SG; Smolek T; Cubinkova V; Žilka N; Spillantini MG; Tolkovsky AM; Goedert M; Aigbirhio FI
ACS Chem Neurosci; 2021 Jun; 12(11):1885-1893. PubMed ID: 33689290
[TBL] [Abstract][Full Text] [Related]
30. Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice.
Attems J; Ittner A; Jellinger K; Nitsch RM; Maj M; Wagner L; Götz J; Heikenwalder M
J Neural Transm (Vienna); 2011 May; 118(5):737-45. PubMed ID: 21442354
[TBL] [Abstract][Full Text] [Related]
31. Neuronal Expression of Truncated Tau Efficiently Promotes Neurodegeneration in Animal Models: Pitfalls of Toxic Oligomer Analysis.
Skrabana R; Kovacech B; Filipcik P; Zilka N; Jadhav S; Smolek T; Kontsekova E; Novak M
J Alzheimers Dis; 2017; 58(4):1017-1025. PubMed ID: 28527208
[TBL] [Abstract][Full Text] [Related]
32. A comparative study on pathological features of transgenic rat lines expressing either three or four repeat misfolded tau.
Valachova B; Brezovakova V; Bugos O; Jadhav S; Smolek T; Novak P; Zilka N
J Comp Neurol; 2018 Aug; 526(11):1777-1789. PubMed ID: 29633258
[TBL] [Abstract][Full Text] [Related]
33. The protective effects of Esculentoside A through AMPK in the triple transgenic mouse model of Alzheimer's disease.
He Z; Zhang H; Li X; Tu S; Wang Z; Han S; Du X; Shen L; Li N; Liu Q
Phytomedicine; 2023 Jan; 109():154555. PubMed ID: 36610160
[TBL] [Abstract][Full Text] [Related]
34. Memantine prevents sensitivity to excitotoxic cell death of rat cortical neurons expressing human truncated tau protein.
Cente M; Mandakova S; Filipcik P
Cell Mol Neurobiol; 2009 Sep; 29(6-7):945-9. PubMed ID: 19291393
[TBL] [Abstract][Full Text] [Related]
35. The self-perpetuating tau truncation circle.
Zilka N; Kovacech B; Barath P; Kontsekova E; Novák M
Biochem Soc Trans; 2012 Aug; 40(4):681-6. PubMed ID: 22817716
[TBL] [Abstract][Full Text] [Related]
36. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
Saul A; Sprenger F; Bayer TA; Wirths O
Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
[TBL] [Abstract][Full Text] [Related]
37. Female hippocampus vulnerability to environmental stress, a precipitating factor in Tau aggregation pathology.
Sotiropoulos I; Silva J; Kimura T; Rodrigues AJ; Costa P; Almeida OF; Sousa N; Takashima A
J Alzheimers Dis; 2015; 43(3):763-74. PubMed ID: 25159665
[TBL] [Abstract][Full Text] [Related]
38. Progressive tauopathy in P301S tau transgenic mice is associated with a functional deficit of the olfactory system.
Yang S; Kuan WL; Spillantini MG
Eur J Neurosci; 2016 Sep; 44(6):2396-403. PubMed ID: 27422327
[TBL] [Abstract][Full Text] [Related]
39. Viral Delivery of Non-Mutated Human Truncated Tau to Neurons Recapitulates Key Features of Human Tauopathy in Wild-Type Mice.
Vogels T; Vargová G; Brezováková V; Quint WH; Hromádka T
J Alzheimers Dis; 2020; 77(2):551-568. PubMed ID: 32675411
[TBL] [Abstract][Full Text] [Related]
40. AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576.
Otth C; Concha II; Arendt T; Stieler J; Schliebs R; González-Billault C; Maccioni RB
J Alzheimers Dis; 2002 Oct; 4(5):417-30. PubMed ID: 12446973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
